175.94
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $175.94, with a volume of 401.84K.
It is up +0.01% in the last 24 hours and down -7.25% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$175.92
Open:
$176.47
24h Volume:
401.84K
Relative Volume:
0.38
Market Cap:
$19.57B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
21.04
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
-0.07%
1M Performance:
-7.25%
6M Performance:
-0.63%
1Y Performance:
+14.98%
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DGX
Quest Diagnostics Inc
|
175.94 | 19.57B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
580.74 | 217.58B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.32 | 163.50B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
688.48 | 54.95B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
138.39 | 39.21B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
226.92 | 38.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Pacer Advisors Inc. Grows Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Assenagon Asset Management S.A. Lowers Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? - Yahoo Finance
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Quest Diagnostics Incorporated $DGX Shares Sold by Coho Partners Ltd. - MarketBeat
Voya Investment Management LLC Reduces Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Thrivent Financial for Lutherans Purchases 11,351 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Corient Private Wealth LLC Has $4.49 Million Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
What is the fair value of Quest Diagnostics Incorporated stock now2025 Bull vs Bear & Expert Curated Trade Setups - Улправда
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire
Quest Diagnostics Incorporated's (NYSE:DGX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Quest Diagnostics Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
What market sentiment indicators show for Quest Diagnostics Incorporated (QDI) stockStock Surge & Proven Capital Preservation Tips - DonanımHaber
Is Quest Diagnostics Incorporated stock a buy during volatile markets2025 Winners & Losers & Weekly Stock Performance Updates - DonanımHaber
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Is Quest Diagnostics Incorporated stock a safe haven asset2025 Volume Leaders & High Yield Equity Trading Tips - Улправда
How Quest Diagnostics Incorporated stock trades after rate cutsJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - Улправда
Aaron Wealth Advisors LLC Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Quest Diagnostics stock: Is DGX outperforming the healthcare sector? - MSN
Quest Diagnostics (NYSE:DGX) Shares Unloaded Rep. Julie Johnson - MarketBeat
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? - Barchart.com
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bellevue Group AG Makes New $8.72 Million Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock - Yahoo Finance
Bayesian Capital Management LP Takes Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Looking Into Quest Diagnostics Inc's Recent Short Interest - Sahm
California Public Employees Retirement System Reduces Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Marshall Wace LLP Reduces Position in Quest Diagnostics Incorporated $DGX - MarketBeat
First Trust Advisors LP Sells 114,868 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Invesco Ltd. Raises Position in Quest Diagnostics Incorporated $DGX - MarketBeat
New York State Common Retirement Fund Sells 7,619 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Can Quest Diagnostics Incorporated (QDI) stock hold up in economic slowdownTrade Exit Report & Safe Entry Zone Identification - Newser
Will Quest Diagnostics Incorporated stock outperform benchmarksJuly 2025 Trends & Real-Time Chart Breakout Alerts - Newser
1,325,624 Shares in Quest Diagnostics Incorporated $DGX Purchased by Norges Bank - MarketBeat
Korea Investment CORP Purchases 12,300 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-03 05:06:27 - Newser
Blueshift Asset Management LLC Has $636,000 Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated (QDI) stock ideal for retirement investorsPortfolio Performance Report & Daily Volume Surge Signals - Newser
Is Quest Diagnostics Incorporated stock nearing a technical breakoutExit Point & Expert Approved Momentum Ideas - Newser
Mackenzie Financial Corp Has $28.11 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Schroder Investment Management Group Buys 122,646 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated stock cheap vs fundamentalsJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Why analysts maintain buy rating on Quest Diagnostics Incorporated stockBreakout Watch & Low Drawdown Momentum Ideas - Newser
Russell Investments Group Ltd. Acquires 25,768 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-02 04:36:26 - Newser
How cyclical is Quest Diagnostics Incorporated stock compared to rivals2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Distillate Capital Partners LLC Sells 4,577 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Hsbc Holdings PLC Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):